• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子在垂体腺瘤发病机制中的作用:综述

Role of transcription factors in the pathogenesis of pituitary adenomas: a review.

作者信息

Suhardja A, Kovacs K, Rutka J

机构信息

Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada.

出版信息

J Neurooncol. 2001 Dec;55(3):185-93. doi: 10.1023/a:1013819827162.

DOI:10.1023/a:1013819827162
PMID:11859974
Abstract

The diversity inherent in every organ has its roots in gene-expression variation and is revealed through distinctions in the molecular profile and hence the identity of individual cell type. Study into the molecular mechanisms of the development of individual cell type within the pituitary, which is under the control of transcription factors, has provided a basis for a deeper insight into the molecular mechanisms underlying the pathogenesis of a variety of hormone-producing pituitary tumors. Identification of some of these transcription factors in pituitary adenomas further supports their role in the pathogenesis of pituitary adenomas. Understanding the molecular mechanisms of regulation of proliferation of pituitary cell types by transcription factors offers a basis for hope that rational genetic or pharmacologic therapies for pituitary tumors can be designed in the future.

摘要

每个器官固有的多样性源于基因表达变异,并通过分子特征的差异以及由此产生的个体细胞类型的特性得以展现。对垂体中在转录因子控制下的个体细胞类型发育的分子机制进行研究,为更深入了解各种产生激素的垂体肿瘤发病机制背后的分子机制提供了基础。在垂体腺瘤中鉴定出其中一些转录因子,进一步支持了它们在垂体腺瘤发病机制中的作用。了解转录因子对垂体细胞类型增殖的调控分子机制,为未来能够设计出针对垂体肿瘤的合理基因或药物疗法带来了希望。

相似文献

1
Role of transcription factors in the pathogenesis of pituitary adenomas: a review.转录因子在垂体腺瘤发病机制中的作用:综述
J Neurooncol. 2001 Dec;55(3):185-93. doi: 10.1023/a:1013819827162.
2
Association with c-Myc: an alternated mechanism for c-Myc function.与c-Myc的关联:c-Myc功能的一种交替机制。
Curr Top Microbiol Immunol. 1995;194:273-82. doi: 10.1007/978-3-642-79275-5_32.
3
Transcription factors in normal and neoplastic pituitary tissues.正常及肿瘤性垂体组织中的转录因子。
Microsc Res Tech. 1997 Oct 15;39(2):168-81. doi: 10.1002/(SICI)1097-0029(19971015)39:2<168::AID-JEMT8>3.0.CO;2-H.
4
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.Myc-Max异源二聚体激活一个DEAD盒基因,并在体内与多个E盒相关位点相互作用。
EMBO J. 1996 Aug 15;15(16):4344-57.
5
Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.人垂体腺瘤中生长相关因子的定量分析。生长激素分泌型腺瘤中胰岛素样生长因子-I及其受体mRNA水平降低。
Regul Pept. 1999 Aug 31;83(1):31-8. doi: 10.1016/s0167-0115(99)00048-8.
6
Design of dominant negatives to bHLHZip proteins that inhibit DNA binding.
Curr Top Microbiol Immunol. 1997;224:169-77. doi: 10.1007/978-3-642-60801-8_17.
7
Genetic basis of pituitary adenoma invasiveness: a review.垂体腺瘤侵袭性的遗传基础:综述
J Neurooncol. 2001 May;52(3):195-204. doi: 10.1023/a:1010655419332.
8
Pit-1 gene expression in human pituitary adenomas.人垂体腺瘤中的Pit-1基因表达
Horm Res. 1997;47(4-6):251-8. doi: 10.1159/000185472.
9
Expression of c-myc and c-fos and binding sites for estradiol and progesterone in human pituitary tumors.人垂体瘤中c-myc和c-fos的表达以及雌二醇和孕酮的结合位点
Neurol Res. 1998 Dec;20(8):709-12. doi: 10.1080/01616412.1998.11740588.
10
Expression and alternative splicing of Pit-1 messenger ribonucleic acid in pituitary adenomas.垂体腺瘤中Pit-1信使核糖核酸的表达及可变剪接
Neurosurgery. 1996 Feb;38(2):362-6. doi: 10.1097/00006123-199602000-00026.

引用本文的文献

1
Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies.垂体腺瘤表达模式分析表明,NeuroD1转录因子在神经内分泌肿瘤靶向治疗中具有潜在作用。
Oncotarget. 2019 Jan 8;10(3):289-312. doi: 10.18632/oncotarget.26513.
2
Pathogenesis analysis of pituitary adenoma based on gene expression profiling.基于基因表达谱的垂体腺瘤发病机制分析
Oncol Lett. 2014 Dec;8(6):2423-2430. doi: 10.3892/ol.2014.2613. Epub 2014 Oct 13.
3
Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas.

本文引用的文献

1
Surfing the p53 network.探索p53网络
Nature. 2000 Nov 16;408(6810):307-10. doi: 10.1038/35042675.
2
New pituitary oncogenes.新的垂体癌基因。
Endocr Relat Cancer. 2000 Mar;7(1):3-15. doi: 10.1677/erc.0.0070003.
3
Pituitary tumor transforming gene (PTTG) transforming and transactivation activity.垂体肿瘤转化基因(PTTG)的转化和反式激活活性。
垂体腺瘤中 PIK3CA 原癌基因的突变和基因组扩增。
Braz J Med Biol Res. 2012 Sep;45(9):851-5. doi: 10.1590/s0100-879x2012007500115. Epub 2012 Jul 12.
4
Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen.垂体特异性转录因子-1(Pit-1)在促性腺激素细胞细胞核中的免疫定位表明,雌激素诱导的催乳素瘤中促性腺激素细胞向催乳激素细胞发生了转分化。
Histochem Cell Biol. 2004 Jun;121(6):453-62. doi: 10.1007/s00418-004-0661-5. Epub 2004 Jun 9.
J Biol Chem. 2000 Mar 17;275(11):7459-61. doi: 10.1074/jbc.275.11.7459.
4
The coregulator exchange in transcriptional functions of nuclear receptors.核受体转录功能中的共调节因子交换
Genes Dev. 2000 Jan 15;14(2):121-41.
5
Function of the c-Myc oncogenic transcription factor.c-Myc致癌转录因子的功能。
Exp Cell Res. 1999 Nov 25;253(1):63-77. doi: 10.1006/excr.1999.4686.
6
Pax2 in development and renal disease.发育及肾脏疾病中的Pax2
Int J Dev Biol. 1999;43(5):463-8.
7
The retinoblastoma protein is linked to the activation of Ras.视网膜母细胞瘤蛋白与Ras的激活有关。
Mol Cell Biol. 1999 Nov;19(11):7724-32. doi: 10.1128/MCB.19.11.7724.
8
Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element.雌激素对细胞周期蛋白D1启动子的诱导作用:一种类似cAMP反应元件的参与。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11217-22. doi: 10.1073/pnas.96.20.11217.
9
The transcriptional basis of steroid physiology.
Cold Spring Harb Symp Quant Biol. 1998;63:577-85. doi: 10.1101/sqb.1998.63.577.
10
Gene transcription by recruitment.通过募集进行基因转录。
Cold Spring Harb Symp Quant Biol. 1998;63:167-71. doi: 10.1101/sqb.1998.63.167.